VIMOVO

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Dostupné s:

ASTRA ZENECA ISRAEL LTD

ATC kód:

G02CC02

Léková forma:

TABLETS MODIFIED RELEASE

Podání:

PER OS

Výrobce:

ASTRA ZENECA AB., SWEDEN

Terapeutické skupiny:

NAPROXEN

Terapeutické indikace:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Datum autorizace:

2011-12-01